Procurement Summary
Country : Ireland
Summary : Ag3147c Ul Rft for the Provision of a Preclinical Bioavailability Study for a Drug Nanoparticle Formulation
Deadline : 28 Mar 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 115920538
Document Ref. No. : 5251201
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Our objective is to conduct a study in animals that compares the pharmacokinetics of 2 oral formulations of the same drug or active pharmaceutical ingredient (API). One of the oral formulations is developed inhouse (Nanocomp), and the other is a formulation currently available in the market (Commercial). The question we intend to answer using standard pharmacokinetic analysis is: would the novel oral formulation be superior to the available formulation?
Procedure : Open
Publication Date : 28/03/2025
Deadline : 28/03/2025 14:00:00
Documents
Tender Notice